Interleukin-1β-induced promatrilysin expression is mediated by NFκB-regulated synthesis of interleukin-6 in the prostate carcinoma cell line, LNCaP1

Neoplasia

Volumn 3, Issue 6, 2001, Pages 509-520

  Maliner Stratton, Mimi Suzanne ^a   Klein, Russell D ^b   Udayakumar, Thirupandiyur S ^a   Nagle, Raymond B ^a   Bowden, George Timothy ^a,c  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

Interleukin 1; Interleukin 6; Matrilysin; Matrix metalloproteinase; Prostate

Indexed keywords

CYCLOHEXIMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MATRILYSIN; MATRIX METALLOPROTEINASE; PROMATRILYSIN; STAT3 PROTEIN; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; ENZYME PRECURSOR; INTERLEUKIN 1; MESSENGER RNA; METALLOPROTEINASE; PROTEIN SYNTHESIS INHIBITOR; PYRROLIDINE DERIVATIVE; PYRROLIDINE DITHIOCARBAMIC ACID; RNA; SALAZOSULFAPYRIDINE; STAT3 PROTEIN, HUMAN; THIOCARBAMIC ACID DERIVATIVE; TRANSACTIVATOR PROTEIN; TUMOR PROTEIN;

ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; TRANSACTIVATION; ADENOCARCINOMA; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME INDUCTION; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR;

ADENOCARCINOMA; CYCLOHEXIMIDE; DNA-BINDING PROTEINS; ENZYME INDUCTION; ENZYME PRECURSORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; MALE; METALLOENDOPEPTIDASES; NEOPLASM PROTEINS; NF-KAPPA B; PROSTATIC NEOPLASMS; PROTEIN SYNTHESIS INHIBITORS; PYRROLIDINES; RNA, MESSENGER; RNA, NEOPLASM; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SULFASALAZINE; THIOCARBAMATES; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0034747526     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900178     Document Type: Article

References (58)

1. Matrix metalloproteinases in tumour invasion and metastasis
2. Matrix metalloproteinases and oral cancer
3. Matrix metalloproteinase family
4. Metalloproteinase domain structure, cellular invasion and metastasis
5. Metalloproteinase expression and hormonal regulation during tissue remodeling in the cycling human endometrium
6. Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers
7. Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model
8. Suppression of matrilysin inhibits colon cancer cell invasion in vitro
9. Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice
10. Localization and expression of matrix metalloproteinase-7 in human prostate
11. Matrilysin expression in human prostate carcinoma
12. Structure and expression of the human gene for the matrix metalloproteinase matrilysin
13. Matrilysin expression in the involuting rat ventral prostate
14. Interleukin-1 beta secreted from monocytic cells induces the expression of matrilysin in the prostatic cell line LNCaP
15. LPS and specific T cell responses: Interleukin 1 (IL 1)-independent amplification of antigenspecific T helper (TH) cell proliferation
16. Analysis of interleukin (IL)-1 beta and transforming growth factor (TGF)-beta-induced signal transduction pathways in IL-2 and TGF-beta secretion and proliferation in the thymoma cell line EL4.NOB-1
17. Interleukin-1 beta, but not IL-1 alpha, stimulates cell proliferation in the adrenal cortex
18. Autocrine growth of CD4+ T cells. Differential effects of IL-1 on helper and inflammatory T cells
19. Central IL-1 differentially regulates peripheral IL-6 and TNF synthesis
20. EGF induces the expression of matrilysin in the human prostate adenocarcinoma cell line
21. Resistance to IL-1 anti-proliferative effect, accompanied by characteristics of advanced melanoma, permits invasion of human melanoma cells in vitro, but not metastasis in the nude mouse
22. Plasminogen modulation of IL-1-stimulated degradation in bovine and human articular cartilage explants. The role of the endogenous inhibitors: PAI-1, alpha 2-antiplasmin, alpha 1-PI, alpha 2-macroglobulin and TIMP
23. IL-1-mediated expression of membrane type matrix-metallo-proteinase in rheumatoid osteoblasts [In Process Citation]
24. The role of IL-4 and IL-6 in IL-1-dependent cartilage matrix degradation
25. Dual regulation of IL-1 beta-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-kappa B and AP-1
26. IL-12 regulates VEGF and MMPs in a murine breast cancer model
27. Interleukin 10 (IL-10) inhibition of primary human prostate cell-induced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion
28. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase-and cathepsin-dependent emphysema
29. Nuclear factor kappa B/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1 beta-stimulated synovial fibroblasts
30. Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappa B elements
31. Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate
32. Activation of the Stat3 signaling pathway is required for differentiation by interleukin-6 in PC12-E2 cells
33. Effects of TNF-alpha and IL-1 beta on mucin, lysozyme, IL-6 and IL-8 in passage-2 normal human nasal epithelial cells
34. Inhibition of NF-kappa B by pyrrolidine dithiocarbamate blocks endothelial cell activation
35. Inhibition of nuclear factor kappa B and induction of apoptosis in T-lymphocytes by sulfasalazine
36. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence
37. IL-1 stimulates IL-6 production in endothelial cells
38. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro
39. Characterization of the role of IL-6 in the progression of prostate cancer
40. Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas
41. Induced nitric oxide inhibits IL-6-induced stat3 activation and type II acute phase mRNA expression [In Process Citation]
42. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: Generation and characterization of T cell-specific Stat3-deficient mice
43. STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP
44. STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells
45. Correlation of histological inflammation in needle biopsy specimens with serum prostate-specific antigen levels in men with negative biopsy for prostate cancer
46. High-grade inflammation in prostate cancer as a prognostic factor for biochemical recurrence after radical prostatectomy
47. Elevated levels of circulating interleukin-6 and transforming growth factor-beta 1 in patients with metastatic prostatic carcinoma
48. Modulation of osteoclast differentiation by local factors
49. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors
50. The matrix metalloprotease matrilysin (PUMP) is expressed in developing human mononuclear phagocytes
51. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease
52. Interleukin-6 increases rat metalloproteinase-13 gene expression through stimulation of activator protein 1 transcription factor in cultured fibroblasts
53. Proteolytic activity of human non-Hodgkin's lymphomas
54. Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer
55. Development of human prostate cancer cells to neuroendocrine-like cells by interleukin-1
56. Enhancement of antiproliferative effects of interleukin-1 beta and tumor necrosis factoralpha on human prostate cancer LNCaP cells by coculture with normal fibroblasts through secreted interleukin-6
57. Significant correlation between expression of interleukin-1 alpha and liver metastasis in gastric carcinoma
58. Heterogeneity of cytokine and growth factor gene expression in human melanoma cells with different metastatic potentials